- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Ulcerative colitis
- Meeting Date: November 2024
- Public Summary Document (PSD) November 2024 PBAC Meeting - (PDF 574KB)
- Public Summary Document (PSD) November 2024 PBAC Meeting - (Word 156KB)
Budesonide – November 2024
Budesonide; Suppository 4 mg; Budenofalk®
Last updated
30 May 2025